article thumbnail

Galderma’s Nemolizumab Approved for AD and PN in the UK and Switzerland

The Dermatology Digest

Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN.

article thumbnail

Utilizing Biologics in the Management of Moderate to Severe Atopic Dermatitis

Dermatology Times

April Armstrong, MD, MPH, and Peter Lio, MD, explained the science behind how AD impacts quality of life and biologics on the market to enhance treatment plans.

article thumbnail

Derm-Biome Adds Dr. Jerry Tan to Its Scientific Advisory Board

The Dermatology Digest

Jerry Tan, is a dermatologist in Windsor, ON, the immediate past President of the Acne and Rosacea Society of Canada, co-chair of the Acne Core Outcomes Research Network (ACORN), Derm-Biome Pharmaceuticals develops topical treatments for acne, atopic dermatitis, and precancerous skin conditions.

article thumbnail

FDA, EMA Accept Galderma’s BLA for Nemolizumab for PN and AD

The Dermatology Digest

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

article thumbnail

Study: Including pH Levels on Cleanser Labels May Be Beneficial for Folks With AD

The Dermatology Digest

Liquid synthetic detergents are more likely to be acidic than other cleansers, making them a better option for people with atopic dermatitis (AD). of marketed cleansers disclosed pH. ” in 3 whose measured pH was actually 4.40 Only 12.8% of liquid syndets were acidic and 11% neutral.

article thumbnail

How Contact Dermatitis Can Result from ‘Natural’ Skin Care Products

First Derm

The research letter published in JAMA Dermatology revealed that numerous products marketed as “clean” and “natural” can still trigger skin problems due to the presence of ingredients that may contribute to allergic contact dermatitis. This can result in contact dermatitis and other adverse skin reactions.

article thumbnail

Transcutaneous Sensitization: The Real Skinny on Food-based Emollients and Skincare Products

The Dermatology Digest

As such, children with atopic dermatitis (AD) are thought to be more susceptible to food allergies due to the transfer of allergens through their broken skin barrier. patients often face a deluge of marketing that adds to confusion with a host of products claiming to be “natural and safe.” References: Shaker M, Murray RGP, Mann JA.